PT Bundamedik Tbk (ISX:BMHS) Cash Flow for Dividends: Rp0 Mil (TTM As of Mar. 2026)


ISX:BMHS PT Bundamedik Tbk ISX:BMHS
60 GF Score
Price Rp171.00
GF Value Rp305.31
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PT Bundamedik Tbk Cash Flow for Dividends?

PT Bundamedik Tbk ISX:BMHS -3.39% 60 Cash Flow for Dividends is Rp0 Mil as of Mar. 2026. GuruFocus rates ISX:BMHS with a GF Score™ of 60/100 and a GF Value™ of Rp305.31 (Possible Value Trap). The stock has 4 warning signs investors should review.

PT Bundamedik Tbk's cash flow for dividends for the three months ended in Mar. 2026 was Rp0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was Rp0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

PT Bundamedik Tbk's annual payment of dividends increased from Dec. 2023 (Rp-22,787 Mil) to Dec. 2024 (Rp-63,931 Mil) but then declined from Dec. 2024 (Rp-63,931 Mil) to Dec. 2025 (Rp-16,403 Mil).

PT Bundamedik Tbk Cash Flow for Dividends Related Terms

PT Bundamedik Tbk Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for PT Bundamedik Tbk's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Bundamedik Tbk Cash Flow for Dividends Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial -40,854.78 -140,280.01 -22,787.45 -63,930.61 -16,403.10

PT Bundamedik Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:BMHS
60GF Score
PT Bundamedik Tbk ISX:BMHS
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Bundamedik Tbk Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of Rp0 Mil mean?
PT Bundamedik Tbk (ISX:BMHS) has a Cash Flow for Dividends of Rp0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for PT Bundamedik Tbk and its competitors.
Is PT Bundamedik Tbk's Cash Flow for Dividends too high?
PT Bundamedik Tbk's current Cash Flow for Dividends is Rp0 Mil. Overall, PT Bundamedik Tbk has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's Cash Flow for Dividends compare to HCA and THC?
PT Bundamedik Tbk's Cash Flow for Dividends of Rp0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for PT Bundamedik Tbk and its competitors. PT Bundamedik Tbk's current Cash Flow for Dividends is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Possible Value Trap. The stock's GF Value™ is Rp305.31, compared to a current price of Rp171.00 — trading 44% below its estimated fair value. The current Cash Flow for Dividends is Rp0 Mil. PT Bundamedik Tbk's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current Cash Flow for Dividends is Rp0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued. The current stock price of Rp171.00 is trading 44% below its estimated GF Value™ of Rp305.31. GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.

Key valuation signals for ISX:BMHS:

  • Cash Flow for Dividends: Rp0 Mil
  • GF Value™: Rp305.31 vs. price of Rp171.00 (44% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Bundamedik Tbk Business Description

Address Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
60GF Score

Get the complete analysis for ISX:BMHS

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp171.00
Price
Rp305.31
GF Value